新 和 成 (002001)
Zhejiang NHU Company Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 307342.17
- Circulating A-Shares(W): 303686.19
- Earnings Per Share(RMB): 1.7300
- Net Assets Per Share(RMB): 10.4779
- Operating Revenue(W RMB): 1664210.18
- Total Profit(W RMB): 624426.25
- Net Profit Attributable to Parent(W RMB): 532072.17
- Net Profit Growth Rate(%): 33.37
- Weighted Return on Equity(%): 17.3200
- Operating Cash Flow Per Share(RMB): 1.8360
- Undistributed Profit Per Share(RMB): 7.9864
- Capital Reserve Per Share(RMB): 1.0192
2. Main Business
The main business covers:
- Nutrition Products
- Flavors and Fragrances
- Polymer Materials
- Production and Sales of Active Pharmaceutical Ingredients (APIs)
3. Company Basic Information
- Company Name: Zhejiang NHU Co., Ltd.
- Listing Date: 2004-06-25
- Industry: Pharmaceutical Manufacturing
- Address: No. 418, West Xinchang Avenue, Qixing Street, Xinchang County, Zhejiang Province, China
- Website: www.cnhu.com
- Company Profile: Zhejiang NHU Co., Ltd. was established as a joint stock limited company with the approval of the former Zhejiang Provincial Government Securities Committee (Document No. ZJZWB [1999] No. 9). The company was jointly sponsored by Xinchang Synthetic Chemical Plant, Zhang Pingyi, Yuan Yizhong, Shi Cheng, Hu Baoyan, Shi Guanqun, Wang Xuewen, Shi Sanfu, Cui Xinrong, and Wang Xulin. The company was officially registered on April 5, 1999.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | NHU Holding Group Co., Ltd. | General Legal Person | 153923.24 | 50.68 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 18523.37 | 6.10 |
| 3 | Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Huizhi Fund | General Legal Person | 2693.07 | 0.89 |
| 4 | Huatai-PineBridge CSI 300 ETF | Fund | 2611.72 | 0.86 |
| 5 | National Social Security Fund 503 Portfolio | Social Security Fund | 2500.00 | 0.82 |
| 6 | E Fund CSI 300 Healthcare ETF | Fund | 1925.67 | 0.63 |
| 7 | Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Caizhi Fund | General Legal Person | 1915.08 | 0.63 |
| 8 | E Fund CSI 300 ETF | Fund | 1891.39 | 0.62 |
| 9 | Shanghai Chongyang Strategic Investment Co., Ltd. - Chongyang Strategic Juzhi Fund | Asset Management Plan | 1509.67 | 0.50 |
| 10 | ChinaAMC CSI 300 ETF | Fund | 1411.35 | 0.46 |
5. Concept Sectors
- Vitamins
- Fluorine Concept
- New Materials
- Synthetic Biology
- Margin Trading & Securities Lending
- Low P/E Ratio
- High-Performance Stocks
- Social Security Fund Heavy Holdings
- Share Buyback Plan
- Employee Stock Ownership
- MSCI Constituent
- Northbound Capital Heavy Holdings
- Non-Cyclical Stocks
- Special Loans
- Free Cash Flow
- CSI 100
- SZSE Value
- Galaxy 99
- CSI Medium and Small Cap 100
- SZSE SME 100
- Mid-Cap Growth
- Mid-Cap Value
- SZSE 100
- SZSE 300
- SZSE Dividend
- SZSE Corporate Governance
- SZSE Private Enterprise 100
- SZSE Growth
- SZSE Value
- SZSE Growth
- CSI 300
- Tencent Ji'an Index
- SZSE SME 300
- CSI 200
- CSI 300 Non-Cyclical
- SZSE Innovation
- Innovation 100
- CSI 300 ESG
- Guoxin Value
- SZSE 50
- SZSE Main Board 50
- CSI A100
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information